
Validea's guru fundamental report rates UnitedHealth Group Inc. (UNH) at 77% using its Martin Zweig-based Growth Investor model, placing it just under the 80% threshold for 'some interest' for growth investors. The large-cap insurer, evaluated for accelerating earnings and sales growth, reasonable valuations, and low debt, exhibited a mixed performance against the model's criteria, notably failing on revenue growth relative to EPS growth and earnings growth rate over several quarters, while passing on P/E ratio and sales growth.
UnitedHealth Group (UNH) shows a mixed but largely positive fundamental profile according to Validea's Martin Zweig-based growth model, scoring 77%, which is just below the 80% threshold that indicates model interest. The company's strengths are evident in its reasonable P/E ratio, positive sales growth rate, and strong recent earnings performance, with current quarterly EPS growth surpassing that of the prior three quarters. Furthermore, the model signals confidence in the company's long-term EPS growth trajectory and notes positive insider transaction activity. However, several key weaknesses warrant caution. The analysis reveals a failure on revenue growth in relation to EPS growth, suggesting that bottom-line expansion may be outpacing top-line business growth, a potential red flag for sustainability. Additionally, the model indicates a lack of consistent earnings acceleration over the past several quarters and notes that the current quarter's EPS growth, while strong, did not exceed the company's own historical growth rate, pointing to a potential deceleration from its long-term trend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment